agilon health (NYSE:AGL) Rating Lowered to “Market Perform” at William Blair

agilon health (NYSE:AGLGet Free Report) was downgraded by equities research analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Friday,Briefing.com Automated Import reports.

Several other brokerages also recently weighed in on AGL. Deutsche Bank Aktiengesellschaft cut their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Benchmark restated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Citigroup reissued a “sell” rating and set a $2.50 price objective (down from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. Finally, Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Three equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $7.81.

View Our Latest Stock Report on agilon health

agilon health Stock Performance

Shares of NYSE AGL opened at $2.73 on Friday. The firm’s 50-day moving average price is $3.31 and its 200-day moving average price is $5.00. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.12 billion, a PE ratio of -3.74 and a beta of 0.60. agilon health has a 52-week low of $2.36 and a 52-week high of $13.76.

agilon health (NYSE:AGLGet Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. agilon health’s quarterly revenue was up 38.7% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.04) earnings per share. As a group, analysts anticipate that agilon health will post -0.32 EPS for the current year.

Insider Buying and Selling

In other news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of AGL. Capital International Investors increased its holdings in shares of agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares during the period. AQR Capital Management LLC grew its holdings in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in agilon health during the first quarter worth $2,975,000. Vanguard Group Inc. grew its holdings in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in agilon health during the second quarter worth $1,849,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.